Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
7.8%
% of IBBQ's 218 holdings also in MEDX
56.7%
% of MEDX's 30 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 8.0% | 5.9% | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.6% | 5.7% | 4.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% | 4.7% | 3.7% |
|
REGENERON PHARMACEUTICALS | 7.1% | 2.7% | 2.7% |
|
BIOGEN IDEC INC | 2.0% | 2.4% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to MEDX
|
VERTEX PHARMACEUTICALS INC | 9.1% |
|
GILEAD SCIENCES INC | 7.9% |
|
REGENERON PHARMACEUTICALS | 4.4% |
 |
ARGENX SE ADR | 2.3% |
|
SUMMIT THERAPEUTICS INC | 2.2% |
|
AMGEN INC | 2.1% |
 |
SANOFI-AVENTIS-ADR | 1.7% |
|
ROYALTY PHARMA PLC CLASS A | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.4% |
|
INSMED INC | 1.4% |
IBBQ Underweight Relative to MEDX
|
ELI LILLY & CO | -17.3% |
|
ABBVIE INC | -9.5% |
 |
NOVARTIS AG-ADR | -6.9% |
|
BRISTOL-MYERS SQUIBB CO | -5.6% |
|
JOHNSON & JOHNSON | -5.0% |
 |
ALKERMES PLC | -4.0% |
|
PFIZER INC | -3.9% |
|
MERCK & CO. INC. | -3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
CRISPR THERAPEUTICS AG | -2.2% |